Ro 15-8074, a new cephalosporin the pivaloyloxymethylester of which (Ro 15-8015) is orally absorbable, showed greater in vitro activity than cefaclor ngainst 48 Neisseria gonorrhoeae strains, including 25 penicillinase-producing strains. Unlike cefaclor, Ro 15-8074 was unaffected by increase in ihoculum size, and it exhibited a remarkable stability against gonococcal P-lactamase hydrolysis.
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The emergence of penicillinase-producing Neisseria gonorrhoeae (PPNG) strains showing high resistance to penicillin has prompted the search for effective alternative drugs against these isolates. Although a number of new P-lactam antibiotics have been reported to show promising in vitro and in vivo activities (2, 3, 6, 8, 9) , few can be administered orally. Of these drugs, cefaclor and amoxicillin-clavulanic acid (Augmentin) have been reported to be active against PPNG strains both in vitro and in vivo (4, 10) . In this study, therefore, we evaluated the in vitro activity of Ro 15-8074 in comnparison with those of cefaclor and amoxicillin-clavulanic acid against N. gonorrhoeae strains and also tested their hydrolytic stability to gonococcal P-lactamase. Ro 15-8074 is an aminothiazolyl-2-methoxyiminoacetamido-3-desacetoxy cephalosporanic acid, and its pivaloyloxymethylester, Ro 15-8075, is orally absorbable. After absorptioh, the ester group of Ro 15-8075 is enzymatically split off the cephalosporin ring, giving rise to the active cephalosporanic acid Ro 15-8074 (Fig. 1) .
The 48 N. gonorrhoeae strains tested were clinical isolates The MICs required to inhibit 50 and 90% of the strains and the MIC ranges of the drugs tested against both PPNG and non-PPNG strains are shown in Table 1 . All PPNG strains showed high resistance to amoxicillin, requiring MICs of .8 mg/liter. In comparison, none of the non-PPNG strains required MICs of amoxicillin >4 mg/liter. Although strains of PPNG showed resistance to amoxicillin, the activity of this antibiotic was greatly enhanced when it was combined with the ,-lactamase inhibitor clavulanic acid. This was evident by the 16-to 32-fold reduction in MICs when these strains were tested against amoxicillin-clavulanic acid. The presence of clavulanic acid had no such effect on the MICs of amoxicillin against non-PPNG strains. With the exception of amoxicillin, which clearly differentiated the PPNG from the non-PPNG strains, the distribution of MICs for the other antibiotics did not show marked differences between these two types of strains. Against both PPNG and non-PPNG strains, Ro 15-8074 was the most active antibiotic; its activity is approximately 16 times more effective than that of cefaclor, inhibiting all the isolates at a concentration of 0.125 mg/liter. The effect of increase in inoculum size was determined in 10 randomly selected PPNG strains and 10 non-PPNG strains. When the inocula of these strains were raised from 103 to 106 CFU per spot, the MICs of Ro 15-8074 were not affected significantly, and in no instance was there a difference of greater than fourfold in MICs between the two inoculum sizes (results not shown).
The stability of Ro 15-8074, cefaclor, and amoxicillin to enzymic hydrolysis was tested with other antibiotic substrates against an extract prepared from a PPNG strain. The relative rates of hydrolysis of the different antibiotics as compared with that of penicillin, which was expressed as 100%, are presented in Table 2 . Both cefaclor and amoxicillin were hydrolyzed by the enzyme at 43 and 71% of the rate of penicillin, respectively. No hydrolytic activity of the enzyme was detectable, however, when it was tested against Ro 15-8074. The hydrolysis observed with cefaclor and amoxicillin was inhibited when the enzyme was preincubated for 10 min with 50 ,uM clavulanic acid before the addition of these drugs.
The results of this study show that Ro 15-8074 has a high in vitro activity against N. gonorrhoeae strains, irrespective of whether they produce penicillinase. Its activity is at least 16 times more effective than that of cefaclor, the other oral cephalosporin compared. Unlike the MICs of cefaclor, which were reported to be affected by an increase in inoculum size (1, 5) , the MICs of Ro 15-8074 were unaffected when the inoculum of gonococcal strains was raised to 106 CFU. In view of the good in vitro activity of Ro 15-8074 against both PPNG and non-PPNG strains, its stability to gonococcal 3-lactamase, and the fact that peak levels of Ro 15-8074 in serum after oral administration of 1 g of Ro 15-8075 is 5 mg/liter (data on file, Hoffmann-La Roche Inc.), which is approximately 50 times the concentration required to inhibit all the N. gonorrhoeae strains tested in our laboratory, this new oral cephalosporin warrants further investigation.
